Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2009 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (134)	1/16/2009 8:28:39 PM
From: The Dodgy Ticker	2 Recommendations Read Replies (1) \| Respond to of 418

Dear Fellow Contestants, I can't begin to tell you how much I have enjoyed this year's contest. Y'all are wonderful good sports for letting me win it again. Please send your checks to.........* *Translation: If my PPHM pick doesn't come through BIG, I'm dead meat in this contest. :-) Seriously, I followed the prices from the beginning today up through mid-afternoon, and what volatility! When I first checked, Technetium was in the lead; next I was; a little later, RKRW was, and I was third. When I quit checking, Technetium was back in first, RKRW was second, and I was third. At least portfolio prices are about double what they were this time last year. And, much as I'd like to claim victory this year (please see above), we've never had a repeat winner, and I suspect the odds are against me. Best to all!

To: BulbaMan who wrote (134)	1/20/2009 11:01:09 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 418

Well my 'visit' to the top 10 lasted the three day weekend.........APPY, better known as Aspen, just got covered under an avalanche of sell orders on trial results.

To: BulbaMan who wrote (134)	1/23/2009 6:15:12 PM
From: BulbaMan	Read Replies (3) \| Respond to of 418

1/23/09 update The inauguration of President Obama (wow, it's really true!) did not, regrettably, inaugurate a bull market on Wall Street. That should be no big surprise. After all, as the new Commander in Chief implied in his inaugural address, our nation does include a fair share of "non-believers." For the week, the Nasdaq Composite Index was down -6.00% CYTD, or "Contest Year To Date" (vs. down -2.69% CYTD a week ago). The Nasdaq Biotech Index also declined for the week, closing down -1.32% CYTD (vs. up 2.24% CYTD a week ago). And the Contest median closed down -3.08% CYTD (vs. up .91% CYTD a week ago). (Since the Friday, 1/9/09 closing quotes were used as the 2009 Contest starting prices, I decided to use CYTD, for "Contest Year To Date," rather than YTD in my updates.) ENZYME's portfolio took over first place, closing the week up 6.29% CYTD, the gain being mostly due to the jump by the portfolio's penny stock stem cell play, ACTC. Stem Cell stocks were boosted by news that the FDA gave the go ahead for Geron's embryonic stem cell clinical trial. My own portfolio, also helped a bit by a stem cell play, ASTM, managed to land in second place with a 5.25% CYTD gain. At Friday's close, 11 of the 32 Contest portfolios were in the black and 15 of the 32 beat the NBI. Enjoy the 1st Obama weekend folks! Below is the Top Ten list on 1/23/09: 1/23/09 Rank Name Profit/Loss 1 ENZYME 6,294 2 BULBA 5,254 3 ROBERT 4,797 4 RKRW 4,329 5 FILO 3,364 6 GHMM 3,119 7 THEOX 1,812 8 ASHLEY 1,021 9 SCARAM 231 10 JACKH 142 (All corrections, especially adjustments for splits, greatly appreciated.)